Company Search:
Advanced Search
Sponsored Links
Lumos Diagnostics Holdings Ltd Company Snapshot
Lumos Diagnostics Holdings Ltd operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lumos Diagnostics Holdings Ltd with three other pharmaceutical manufacturers in Australasia: Blis Technologies Ltd of NEW ZEALAND (2021 sales of 10.61 million New Zealand Dollars [US$7.48 million] ), Althea Group Holdings Ltd (11.55 million Australian Dollars [US$8.42 million] of which 76% was Australia), and Regeneus Ltd (7.07 million Australian Dollars [US$5.15 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lumos Diagnostics Holdings Ltd
  Stock Performance Chart for Lumos Diagnostics Holdings Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): 1.09
(Figures in Australian Dollars)
1 Week -5.7%   13 Weeks -14.6%  
4 Weeks n/a   52 Weeks n/a  
Lumos Diagnostics Holdings Ltd Key Data:
  Ticker: LDX Country: Australia
  Exchanges: ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2021 Sales 25,055,000
(Year Ending Jan 2022).
Employees: N/A
  Currency: Australian Dollars Market Cap: 162,915,368
  Fiscal Yr Ends: June Shares Outstanding: 150,152,413
  Share Type: Ordinary Closely Held Shares: 62,900,736
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.